Supports innovative research on novel devices and approaches to improve outcomes for heart failure patients in cardiac surgery.
Funder: Thoracic Surgery Foundation for Research and Education
Due Dates: September 15, 2026 | September 15, 2027
Funding Amounts: $40,000 per year for up to two years (total $80,000)
Summary: Supports innovative basic, pre-clinical, or translational research in cardiac surgery, with a focus on novel devices and improving outcomes for heart failure patients.
This award, named for Arshad Quadri and Joseph Bavaria, is intended to foster innovation in cardiac surgery by supporting research that aims to improve outcomes for patients with cardiac disease, particularly heart failure secondary to heart disease. The focus is on basic, pre-clinical, or translational research involving novel devices—especially those designed to reduce the burden of heart failure from end-stage valvular or other cardiac conditions. Projects related to the function, physiology, and efficacy of new heart valve devices are also eligible.